TH168756A - Pharmaceutical formulation, process, solid form And methods of use related to 1- ethyl-7- (2-methyl-6- (1H-1,2,4-triazole-3-il) pyridin-3-il) -3,4-dai Hydropyracino [2,3-B] Pyracin-2 (1H) -Transfer - Google Patents
Pharmaceutical formulation, process, solid form And methods of use related to 1- ethyl-7- (2-methyl-6- (1H-1,2,4-triazole-3-il) pyridin-3-il) -3,4-dai Hydropyracino [2,3-B] Pyracin-2 (1H) -TransferInfo
- Publication number
- TH168756A TH168756A TH1501006326A TH1501006326A TH168756A TH 168756 A TH168756 A TH 168756A TH 1501006326 A TH1501006326 A TH 1501006326A TH 1501006326 A TH1501006326 A TH 1501006326A TH 168756 A TH168756 A TH 168756A
- Authority
- TH
- Thailand
- Prior art keywords
- pyracin
- ethyl
- methyl
- solid form
- hydropyracino
- Prior art date
Links
- -1 process Substances 0.000 title claims abstract 7
- 238000000034 method Methods 0.000 title claims abstract 5
- 239000007787 solid Substances 0.000 title claims abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract 5
- 238000009472 formulation Methods 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 1
- 230000005591 charge neutralization Effects 0.000 claims 1
- 230000001264 neutralization Effects 0.000 claims 1
- 238000006386 neutralization reaction Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
Abstract
แก้ไข 8-1-59 ที่ได้ให้ในที่นี้คือสูตรผสม, กระบวนการ, รูปแบบของแข็งและวิธีของการใช้ที่เกี่ยวข้องกับ 1-เอธิล-7-(2-เมธิล-6-(1H-1,2,4-ไทรอะโซล-3-อิล)ไพริดิน-3-อิล)-3,4-ไดไฮโดรไพราซิโน[2,3-b] ไพราซิน-2(1H)-โอน ---------------------------------------------------------------------- ที่จัดให้มีในที่นี้เป็นสูตรผสม,กระบวนการ,รูปแบบของแข็ง และวิธีการสำหรับการใช้ ที่ เกี่ยวข้องกับ 1-เอทิล-7-(3-เมทิล-6-(1H-1,2,4-ไทรอะชอล-3-อิล) ไพริดีน-3-อิล)-3,4-ไดไฮโดรไพรา ซิโน(2,3-B)ไพราซิน-2(1H)-โอน สิทธิบัตรยา Revised 8-1-59 given here is the formulation, process, solid form and method of application in relation to 1- ethyl-7- (2-methyl-6- (1H-1,2,4-triazole-3-il) pyridin-3-il) -3,4-dai Hydropyracino [2,3-b] pyracin-2 (1H) - transferred. -------------------------------------------------- -------------------- Supplied herein is Formulation, Process, Solid Form. And methods for use in connection with 1- ethyl -7- (3-methyl-6- (1H-1,2,4-thyachol-3-il) pyridine-3-il) -3,4-dihai Dropira Sino (2,3-B) Pyracin-2 (1H) -Transfer drug patent
Claims (2)
Publications (2)
Publication Number | Publication Date |
---|---|
TH1501006326A TH1501006326A (en) | 2017-10-05 |
TH168756A true TH168756A (en) | 2017-10-05 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018013978A2 (en) | Boronic acid derivatives and therapeutic uses thereof. | |
PH12017501956A1 (en) | Compositions of obeticholic acid and methods of use | |
EA201791692A1 (en) | 4H-PIRROLO [3,2-c] PYRIDIN-4-ONE DERIVATIVES | |
DOP2016000339A (en) | USEFUL HETEROARILO COMPOUNDS AS SUMO ACTIVATOR ENZYME INHIBITORS | |
WO2017070616A3 (en) | Sexually transmitted disease vaccines | |
EA201692301A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
WO2015153959A3 (en) | Small molecule inhibitors of mcl-1 and uses thereof | |
CA2894892A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
WO2016022970A8 (en) | Dihydropteridinone derivatives and uses thereof | |
PH12018501362A1 (en) | Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists | |
JO3543B1 (en) | Modified release orally administered amino acid formulations | |
FR22C1058I1 (en) | 2-FLUORO-N-METHYL-4-[7-(QUINOLINE-6-YLMETHYL) IMIDAZO[1,2-B][1,2,4]TRIAZINE-2-YL]BENZAMIDE TABLET FORMULATION | |
WO2016057658A8 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
GT201700016A (en) | [1,2,4] TRIAZOLO [4,3 -B] PIRIDAZINAS FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES | |
MX2015013155A (en) | Tetrandrine family pharmaceutical formulations and method. | |
CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
CL2016001024A1 (en) | Compounds derived from pyrido [4,3-b] pyrazin-2-carboxamides; preparation procedure; Pharmaceutical composition and use for the treatment of neurodegenerative disorders, schizophrenia, depression, among other diseases. | |
EA201691741A1 (en) | PHARMACEUTICAL COMPOSITION | |
WO2014043336A3 (en) | Tetrandrine pharmaceutical formulations and method | |
WO2016057660A8 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
WO2014165513A3 (en) | Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof | |
TH168756A (en) | Pharmaceutical formulation, process, solid form And methods of use related to 1- ethyl-7- (2-methyl-6- (1H-1,2,4-triazole-3-il) pyridin-3-il) -3,4-dai Hydropyracino [2,3-B] Pyracin-2 (1H) -Transfer | |
AU2013338098A8 (en) | Solid salt form of alpha-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof | |
WO2014159501A3 (en) | Processes for preparing tetrahydroisoquinolines | |
EP3475442A4 (en) | 12(s)-hydroxyeicosatrienoic acid compounds and their use as therapeutic agents |